UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
📖 Full Retelling
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
Read full article at source